ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL

Endometrial cancer is a common gynecological malignancy. With the onset of EC patients younger, conservative treatment with progesterone has become an important option for patients trying to preserve reproductive function. However, progesterone resistance is a key factor affecting the efficacy of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaohong, Xia, Min, Wei, Lina, Guo, Kui, Sun, Rui, Liu, Yao, Qiu, Chunping, Jiang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780207/
https://www.ncbi.nlm.nih.gov/pubmed/36550099
http://dx.doi.org/10.1038/s41419-022-05507-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780207/
https://www.ncbi.nlm.nih.gov/pubmed/36550099
http://dx.doi.org/10.1038/s41419-022-05507-z

Ejemplares similares